https://www.biospace.com/xencor-highlights-cd28-bispecific-antibody-platform-at-aacr-annual-meeting-2023
Xencor Highlights CD28 Bispecific Antibody Platform at AACR Annual Meeting 2023 - BioSpace
Apr 17, 2023 - Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and...
bispecific antibody platformaacr annual meeting